335 related articles for article (PubMed ID: 26809635)
21. DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
Hamada T; Nomura M; Kamikawa Y; Yamada N; Batra SK; Yonezawa S; Sugihara K
Cancer; 2012 Nov; 118(21):5251-64. PubMed ID: 22434549
[TBL] [Abstract][Full Text] [Related]
22. Cyclin D1 gene numerical aberration is a predictive marker for occult cervical lymph node metastasis in TNM Stage I and II squamous cell carcinoma of the oral cavity.
Myo K; Uzawa N; Miyamoto R; Sonoda I; Yuki Y; Amagasa T
Cancer; 2005 Dec; 104(12):2709-16. PubMed ID: 16265665
[TBL] [Abstract][Full Text] [Related]
23. Clinical nodal stage is a significant predictor of outcome in patients with oral cavity squamous cell carcinoma and pathologically negative neck metastases: results of the international consortium for outcome research.
Amit M; Yen TC; Liao CT; Binenbaum Y; Chaturvedi P; Agarwal JP; Kowalski LP; Ebrahimi A; Clark JR; Cernea CR; Brandao SJ; Kreppel M; Zöller J; Fliss D; Bachar G; Shpitzer T; Bolzoni VA; Patel PR; Jonnalagadda S; Robbins KT; Shah JP; Patel SG; Gil Z;
Ann Surg Oncol; 2013 Oct; 20(11):3575-81. PubMed ID: 23775408
[TBL] [Abstract][Full Text] [Related]
24. Nm23-H1 expression of metastatic tumors in the lymph nodes is a prognostic indicator of oral squamous cell carcinoma.
Wang YF; Chen JY; Chang SY; Chiu JH; Li WY; Chu PY; Tai SK; Wang LS
Int J Cancer; 2008 Jan; 122(2):377-86. PubMed ID: 17918157
[TBL] [Abstract][Full Text] [Related]
25. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
26. Prognostic value of lymph node density in node-positive patients with oral squamous cell carcinoma.
Kim SY; Nam SY; Choi SH; Cho KJ; Roh JL
Ann Surg Oncol; 2011 Aug; 18(8):2310-7. PubMed ID: 21336511
[TBL] [Abstract][Full Text] [Related]
27. Circulating Anti-Matrix Metalloproteinase-7 Antibodies May Be a Potential Biomarker for Oral Squamous Cell Carcinoma.
Jiang T; Xie P; Liu H
J Oral Maxillofac Surg; 2016 Mar; 74(3):650-7. PubMed ID: 26454036
[TBL] [Abstract][Full Text] [Related]
28. Increased placenta growth factor mRNA level is significantly associated with progression, recurrence and poor prognosis of oral squamous cell carcinoma.
Cheng SJ; Cheng SL; Lee JJ; Chen HM; Chang HH; Kok SH; Chiang ML; Kuo MY
J Formos Med Assoc; 2013 May; 112(5):253-8. PubMed ID: 23660220
[TBL] [Abstract][Full Text] [Related]
29. Prognostics of Cyclin-D1 expression with chemoradiation response in patients of locally advanced oral squamous cell carcinoma.
Khan H; Gupta S; Husain N; Misra S; Singh N; Negi MP
J Cancer Res Ther; 2014; 10(2):258-64. PubMed ID: 25022375
[TBL] [Abstract][Full Text] [Related]
30. Predictive markers for delayed lymph node metastases and survival in early-stage oral squamous cell carcinoma.
Luksic I; Suton P
Head Neck; 2017 Apr; 39(4):694-701. PubMed ID: 28006084
[TBL] [Abstract][Full Text] [Related]
31. [Clinicopathologic features and prognostic factors of cervical lymph node metastasis in oral squamous cell carcinoma].
Li XM; DI B; Shang YD; Li J; Cheng JM
Ai Zheng; 2005 Feb; 24(2):208-12. PubMed ID: 15694035
[TBL] [Abstract][Full Text] [Related]
32. Cyclo-oxygenase-2 expression is associated with vascular endothelial growth factor C expression and lymph node metastasis in oral squamous cell carcinoma.
Kono M; Watanabe M; Abukawa H; Hasegawa O; Satomi T; Chikazu D
J Oral Maxillofac Surg; 2013 Oct; 71(10):1694-702. PubMed ID: 23809761
[TBL] [Abstract][Full Text] [Related]
33. Overexpression of Platelet-Derived Growth Factor and Its Receptor Are Correlated with Oral Tumorigenesis and Poor Prognosis in Oral Squamous Cell Carcinoma.
Lin LH; Lin JS; Yang CC; Cheng HW; Chang KW; Liu CJ
Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32235327
[TBL] [Abstract][Full Text] [Related]
34. The role of p300 in the tumor progression of oral squamous cell carcinoma.
Cho YA; Hong JS; Choe EJ; Yoon HJ; Hong SD; Lee JI; Hong SP
J Oral Pathol Med; 2015 Mar; 44(3):185-92. PubMed ID: 25154636
[TBL] [Abstract][Full Text] [Related]
35. High expression of interleukin 10 might predict poor prognosis in early stage oral squamous cell carcinoma patients.
Chen CJ; Sung WW; Su TC; Chen MK; Wu PR; Yeh KT; Ko JL; Lee H
Clin Chim Acta; 2013 Jan; 415():25-30. PubMed ID: 22981868
[TBL] [Abstract][Full Text] [Related]
36. Contactin 1 (CNTN1) expression associates with regional lymph node metastasis and is a novel predictor of prognosis in patients with oral squamous cell carcinoma.
Wu HM; Cao W; Ye D; Ren GX; Wu YN; Guo W
Mol Med Rep; 2012 Aug; 6(2):265-70. PubMed ID: 22580838
[TBL] [Abstract][Full Text] [Related]
37. Independent prognostic factors of 861 cases of oral squamous cell carcinoma in Korean adults.
Choi KK; Kim MJ; Yun PY; Lee JH; Moon HS; Lee TR; Myoung H
Oral Oncol; 2006 Feb; 42(2):208-17. PubMed ID: 16249114
[TBL] [Abstract][Full Text] [Related]
38. HSP 27 as possible prognostic factor in patients with oral squamous cell carcinoma.
Lo Muzio L; Leonardi R; Mariggiò MA; Mignogna MD; Rubini C; Vinella A; Pannone G; Giannetti L; Serpico R; Testa NF; De Rosa G; Staibano S
Histol Histopathol; 2004 Jan; 19(1):119-28. PubMed ID: 14702179
[TBL] [Abstract][Full Text] [Related]
39. Loss of NKX3-1 as a potential marker for an increased risk of occult lymph node metastasis and poor prognosis in oral squamous cell carcinoma.
Miyaguchi K; Uzawa N; Mogushi K; Takahashi K; Michikawa C; Nakata Y; Sumino J; Okada N; Mizushima H; Fukuoka Y; Tanaka H
Int J Oncol; 2012 Jun; 40(6):1907-14. PubMed ID: 22344708
[TBL] [Abstract][Full Text] [Related]
40. Prognostic significance of tumor infiltrating immune cells in oral squamous cell carcinoma.
Fang J; Li X; Ma D; Liu X; Chen Y; Wang Y; Lui VWY; Xia J; Cheng B; Wang Z
BMC Cancer; 2017 May; 17(1):375. PubMed ID: 28549420
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
